Body Composition in Older Adults
BODI
An Exploration of Body Composition in Older Adults Undergoing Systemic Anticancer Treatment.
1 other identifier
observational
30
1 country
1
Brief Summary
The primary aim of the study is to explore body composition in older adults (aged 70 years and over) with cancer, undergoing systemic anticancer treatment. Additional aims include to explore the extent of body composition changes and whether changes are tumour specific, the incidence for cancer-related cachexia and sarcopenia and finally, how body composition can inform nutritional management of older adults with cancer. To do this, the investigators applied for and were awarded funding from a company called Nutricia to pay for a band 4 (0.6 WTE for 7 months) to take monthly body composition measures on the patients who are eligible, accepting of assessment by the Senior Adult Oncology Programme (SAOP) and consent to these measures. Measurements will include an analysis from the Bioelectrical Impedance Analysis (BIA) machine which will quantify fat, lean muscle, and water content; waist to hip ratio; handgrip strength; calf circumferences. Socio-demographic data will also be collected. Descriptive data analysis will take place to explore possible trends and associations which may inform future research and drive even further personalised care for this growing and typically underrepresented in research, population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Nov 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 19, 2024
CompletedFirst Posted
Study publicly available on registry
October 8, 2024
CompletedStudy Start
First participant enrolled
November 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedOctober 8, 2024
October 1, 2024
7 months
September 19, 2024
October 4, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Explore body composition in older adults with cancer starting SACT.
means and standard deviations (or medians and interquartile ranges if not normally distributed) of body composition measures taken from all participants at baseline/ first Research Clinic, analysed at end of study will quantify this objective.
7 months
Secondary Outcomes (1)
Explore the extent of body composition changes in older adults with cancer during SACT.
7 months
Other Outcomes (3)
Explore whether there are differences between body composition in older adults with cancer receiving SACT, based on tumour diagnosis
7 months
Explore how body composition can inform nutritional management of older adults with cancer receiving SACT.
7 months
Investigate the incidence for cancer-related cachexia and sarcopenia in older adults with cancer receiving SACT.
7 months
Study Arms (1)
adults aged 70yrs and older, eligible, and accepting of assessment in the SAOP.
Interventions
No intervention; observation cohort study
Eligibility Criteria
adults aged 70 years and older, with a cancer diagnosis who are to receive systemic anti-cancer treatment
You may qualify if:
- Adults eligible and accepting of assessment in the SAOP.
- adults aged 70 years and over
- a cancer diagnosis
- just starting SACT
- able to provide at least 2 data sets during the study period (baseline + at least 1 research clinic visit)
- willing and able to provide written informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Royal Marsden NHS Foundation Trustlead
- Nutricia UK Ltdcollaborator
Study Sites (1)
Royal Marsden Hospital
London, SM2 5PT, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Lucy Eldridge, M.Sc. (Hons) Cancer Care Award
Royal Marsden NHS Foundation Trust
- PRINCIPAL INVESTIGATOR
Megan Pattwell, PGDip Dietetics
Royal Marsden NHS Foundation Trust
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 19, 2024
First Posted
October 8, 2024
Study Start
November 1, 2024
Primary Completion
June 1, 2025
Study Completion
June 1, 2025
Last Updated
October 8, 2024
Record last verified: 2024-10